Market Place
Sourcing Support
Recursion to acquire two Canadian drug discovery startups
09 May 2023 //
BIOPHARMADIVE
Cyclica teams up with ANII to enhance scientific innovation
14 Mar 2023 //
PR NEWSWIRE
Samjin Pharm, Cyclica to conduct joint research on AI novel drug development
02 Aug 2022 //
KOREABIOMED
Cyclica and Arctoris to Expand Partnership to Advance Drug Discovery Programs
23 Mar 2022 //
BUSINESSWIRE
Cyclica launches Perturba Therapeutics creating next-gen oncology biotech
09 Feb 2022 //
BUSINESSWIRE
Cyclica Recruits Big Pharma Veteran Michael Palovich as CSO
01 Feb 2022 //
BUSINESSWIRE
Cyclica and the Structural Genomics Consortium Co-crystallize DCAF1
11 Nov 2021 //
BUSINESSWIRE
Cyclica & IMPACT Team Up to Advance Differentiated Anti-cancer Drug Development
22 Sep 2021 //
BUSINESSWIRE
Vyant Bio and Cyclica Collaborate to Treat CDKL5 Deficiency Disorder
19 Aug 2021 //
GLOBENEWSWIRE
PrecisionLife & Cyclica Sign Strategic Partnership Combining Data-driven Biology
17 May 2021 //
BUSINESSWIRE
PrecisionLife, Cyclica ally to co-market discovery platforms
17 May 2021 //
FIERCE BIOTECH
Cyclica Teams Up with Top-Tier Academic Institutions to Identify a COVID Drug
14 Apr 2021 //
BIOSPACE
Cyclica to use Excelra`s GOSTAR Database to develop AI & ML based Deep Learning
21 Oct 2020 //
PRNEWSWIRE
Cerevel Therapeutics and Cyclica Announce Research Collaboration to Use AI
27 Jul 2020 //
BUSINESSWIRE
Cyclica haalt CAD$23 miljoen op in een serie B-financiering
24 Jun 2020 //
BUSINESSWIRE
Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech
24 Jun 2020 //
BUSINESSWIRE
Cyclica Forms Multi-Year and Multi-Project Drug Discovery Partnership
14 Apr 2020 //
BUSINESSWIRE
Cyclica and AUM Biosciences to Partner on Developing Novel Cancer Therapies
15 Jan 2020 //
BUSINESS WIRE
Translational Medicine Accelerator and Cyclica Partner
08 Jan 2020 //
BUSINESS WIRE
Translational Medicine Accelerator and Cyclica Partner
07 Jan 2020 //
BUSINESS WIRE
Translational Medicine Accelerator and Cyclica Partner
07 Jan 2020 //
BUSINESS WIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.